Cargando…

Matrix Metalloproteinase-11 Gene Polymorphisms as a Risk for Hepatocellular Carcinoma Development in Egyptian Patients

BACKGROUND: Chronic hepatitis C (CHC) virus infection is one of major risk factors of hepatocellular carcinoma (HCC) in Egypt, which is a major cause of cancer mortalityin the world. Matrix metalloproteinase-11 (MMP-11) has an important role in tumor migration and metastasis. Therefore, this study a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saad, Hind, Zahran, Magdy A-H, Hendy, Olfat, Abdel-Samiee, Mohamed, Bedair, Hanan M, Abdelsameea, Eman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046319/ https://www.ncbi.nlm.nih.gov/pubmed/33369474 http://dx.doi.org/10.31557/APJCP.2020.21.12.3725

Ejemplares similares

XRCC1 Gene Polymorphism Increases the Risk of Hepatocellular Carcinoma in Egyptian Population
por: Naguib, Mary, et al.
Publicado: (2020)

The association between micro-RNA gene polymorphisms and the development of hepatocellular carcinoma in Egyptian patients
por: Allam, Maha M., et al.
Publicado: (2021)

Evaluation of Amino Acids Profile as Non-Invasive Biomarkers of Hepatocellular Carcinoma in Egyptians
por: Ghanem, Samar Ebrahim, et al.
Publicado: (2022)

Study of the association between a MICA gene polymorphism and cholangiocarcinoma in Egyptian patients
por: Abdel-Rahman, Adel A.-H., et al.
Publicado: (2022)

Bone morphogenic protein-7 (BMP-7) polymorphism: Susceptibility to cirrhosis and hepatocellular carcinoma after viral hepatitis in Egyptian patients
por: AboShabaan, Hind S., et al.
Publicado: (2023)

Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma
por: Wang, Bin, et al.
Publicado: (2018)

ADAM10 Gene Polymorphism and Its Relationship to Hepatocellular Carcinoma in Egyptian HCV Patients Receiving Direct-Acting Antiviral Therapies (DAAs)
por: Ghanem, Samar, et al.
Publicado: (2023)

MicroRNA-215 as a Diagnostic Marker in Egyptian Patients with Hepatocellular Carcinoma
por: El Mahdy, Hussein Ahmed, et al.
Publicado: (2019)

The Putative Role of Natural Killer Cells in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma
por: Hassona, Mona M, et al.
Publicado: (2021)

Heparanase (HPSE) gene polymorphism (rs12503843) contributes as a risk factor for hepatocellular carcinoma (HCC): a pilot study among Egyptian patients
por: Saad, Faten, et al.
Publicado: (2021)

FIB-5 versus FIB-4 index for assessment of hepatic fibrosis in chronic hepatitis B affected patients
por: Metwally, Khaled, et al.
Publicado: (2020)

Impact of prothrombin and factor V Leiden mutations on the progression of fibrosis in patients with chronic hepatitis C
por: Naguib, Mary, et al.
Publicado: (2022)

Susceptibility patterns and virulence genotypes of Helicobacter pylori affecting eradication therapy outcomes among Egyptian patients with gastroduodenal diseases
por: Asaad, Ahmed Morad, et al.
Publicado: (2023)

Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)

Chemokine receptor CXCR6 gene polymorphism and treatment response of chronic hepatitis C virus in Egyptian patients
por: Hassona, Mona M, et al.
Publicado: (2021)

The Impact of Matrix Metalloproteinase-11 Polymorphisms on Colorectal Cancer Progression and Clinicopathological Characteristics
por: Huang, Hsien-Cheng, et al.
Publicado: (2022)

Risk perception and behavior in Egyptian adolescent pesticide applicators: an intervention study
por: Rohlman, Diane S., et al.
Publicado: (2020)

Acute and Cumulative Effects of Repeated Exposure to Chlorpyrifos on the Liver and Kidney Function among Egyptian Adolescents
por: Ismail, Ahmed A., et al.
Publicado: (2021)

A286 THE ROLE OF A GUT HORMONE VERSUS NUCLEAR FACTOR-KAPPA B IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
por: Abdel-Samiee, M, et al.
Publicado: (2023)

A151 OSEPHAGEAL VARICEAL RECURRENCE 4 YEARS BEYOND ENDOSCOPIC BAND LIGATION IN HEPATITIS C PATIENTS WHO ACHIEVED SUSTAINED VIROLOGICAL RESPONSE WITH ORAL DIRECT ACTING ANTIVIRAL THERAPIES
por: Abdel-Samiee, M, et al.
Publicado: (2023)

Urine Neutrophil Gelatinase-Associated Lipocalin a Possible Diagnostic Marker for Egyptian Hepatocellular Carcinoma Patients
por: Abdelsameea, Eman, et al.
Publicado: (2020)

Investigation of chromosomal aberrations in Egyptian hepatocellular carcinoma patients by fluorescence in situ hybridization
por: Aly, Magdy S., et al.
Publicado: (2010)

LAPTM4B Gene Expression and Polymorphism as Diagnostic Markers of Breast Cancer in Egyptian Patients
por: Shaker, Olfat, et al.
Publicado: (2015)

Association between SIRT1 Gene Polymorphisms and Breast Cancer in Egyptians
por: Rizk, Sherine M., et al.
Publicado: (2016)

Possible Prognostic Potential of RANKL and OPG in Metastatic Breast Cancer Egyptian Females
por: Shaker, Olfat Gamil, et al.
Publicado: (2020)

A Polymorphism in the Microsomal Triglyceride Transfer Protein Can Predict the Response to Antiviral Therapy in Egyptian Patients with Chronic Hepatitis C Virus Genotype 4 Infection
por: Saad, Yasmin, et al.
Publicado: (2014)

Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer
por: Hsieh, Chun-Yu, et al.
Publicado: (2020)

Matrix metalloproteinase gene polymorphisms and oral cancer
por: Pereira, Andresa C., et al.
Publicado: (2012)

The Role of Matrix Metalloproteinase Polymorphisms in Ischemic Stroke
por: Chang, Jason J., et al.
Publicado: (2016)

Association of rs6983267 at 8q24, HULC rs7763881 polymorphisms and serum lncRNAs CCAT2 and HULC with colorectal cancer in Egyptian patients
por: Shaker, Olfat G., et al.
Publicado: (2017)

Matrix Metalloproteinase-2, Squamous Cell Carcinoma Antigen, and Tissue Polypeptide-Specific Antigen Expression in Egyptian Patients with Cervical Carcinoma: Relationship with Prognosis
por: Ahmed, Maha Imam, et al.
Publicado: (2004)

Evaluation of 11 Scoring Functions Performance on Matrix Metalloproteinases
por: Shamsara, Jamal
Publicado: (2014)

Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients
por: Shaker, Mohamed K, et al.
Publicado: (2017)

Association of Fascin and matrix metalloproteinase-9 expression with poor prognostic parameters in breast carcinoma of Egyptian women
por: Youssef, Nermeen Salah, et al.
Publicado: (2014)

Matrix metalloproteinase-9 gene polymorphisms in nasal polyposis
por: Wang, Ling-Feng, et al.
Publicado: (2010)

The Association of Matrix Metalloproteinase Gene Polymorphisms and Periodontitis: An Overview
por: Alotaibi, Dalal H, et al.
Publicado: (2020)

Evaluation of CD44 and CD133 as markers of liver cancer stem cells in Egyptian patients with HCV-induced chronic liver diseases versus hepatocellular carcinoma
por: Rozeik, Mohammed Saeed, et al.
Publicado: (2017)

Role of ICAM-1 and E-selectin gene polymorphisms in pathogenesis of PAOD in Egyptian patients
por: Shaker, Olfat, et al.
Publicado: (2010)

Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma
por: Omar, Ashraf, et al.
Publicado: (2023)

Impact of matrix metalloproteinase-11 gene polymorphisms on development and clinicopathologcial variables of uterine cervical cancer in Taiwanese women
por: Ng, Soo-Cheen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k6q3015go2dqurqj9g2vtk1649